We recently employed a synthetic library to discover nanobody ligands for the angiotensin II type I receptor (AT1R), a prototypical GPCR and important therapeutic target for the treatment of hypertension and kidney disease (8, 15). The gene discussed is AGTR1; the disease is hypertensive disorder.